HK1222673A1 - Aav载体和用於抗aav(腺相关病毒)中和抗体的检测 - Google Patents
Aav载体和用於抗aav(腺相关病毒)中和抗体的检测 Download PDFInfo
- Publication number
- HK1222673A1 HK1222673A1 HK16110663.7A HK16110663A HK1222673A1 HK 1222673 A1 HK1222673 A1 HK 1222673A1 HK 16110663 A HK16110663 A HK 16110663A HK 1222673 A1 HK1222673 A1 HK 1222673A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- virus
- aav
- adeno
- assay
- associated virus
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/075—Adenoviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90241—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845841P | 2013-07-12 | 2013-07-12 | |
| US201361845841P | 2013-07-12 | ||
| PCT/US2014/046428 WO2015006743A1 (en) | 2013-07-12 | 2014-07-11 | Aav vector and assay for anti-aav (adeno-associated virus) neutralizing antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1222673A1 true HK1222673A1 (zh) | 2017-07-07 |
Family
ID=52280652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16110663.7A HK1222673A1 (zh) | 2013-07-12 | 2014-07-11 | Aav载体和用於抗aav(腺相关病毒)中和抗体的检测 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11408899B2 (https=) |
| EP (2) | EP4039813A1 (https=) |
| JP (4) | JP2016525347A (https=) |
| KR (1) | KR102445330B1 (https=) |
| CN (2) | CN116004721A (https=) |
| AU (1) | AU2014287005C1 (https=) |
| CA (1) | CA2918038C (https=) |
| HK (1) | HK1222673A1 (https=) |
| IL (1) | IL243438B (https=) |
| MX (2) | MX2016000345A (https=) |
| RU (1) | RU2705249C2 (https=) |
| WO (1) | WO2015006743A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107635584B (zh) * | 2015-04-09 | 2022-06-17 | 康奈尔大学 | 基因治疗以预防对过敏原的反应 |
| MX390848B (es) | 2015-06-23 | 2025-03-21 | Childrens Hospital Philadelphia | Factor ix modificado, y composiciones, metodos y usos para la transferencia de genes a celulas, organos y tejidos. |
| SG11201802408RA (en) | 2015-11-05 | 2018-05-30 | Bamboo Therapeutics Inc | Modified friedreich ataxia genes and vectors for gene therapy |
| EP3384035A4 (en) * | 2015-12-02 | 2019-08-07 | Voyager Therapeutics, Inc. | ASSAYS FOR THE DETECTION OF AAV-NEUTRALIZING ANTIBODIES |
| EP3645021A4 (en) | 2017-06-30 | 2021-04-21 | Intima Bioscience, Inc. | ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY |
| US20210228738A1 (en) * | 2017-07-17 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
| CN107828821A (zh) * | 2017-11-15 | 2018-03-23 | 四川大学 | 一种腺相关病毒感染敏感的细胞系的构建方法及腺相关病毒中和抗体含量测定的检测方法 |
| CA3086046C (en) | 2017-12-29 | 2023-02-21 | Helixmith Co., Ltd. | Adeno-associated virus (aav) vector having hybrid hgf gene introduced thereto |
| US20190256867A1 (en) | 2018-02-01 | 2019-08-22 | Homology Medicines, Inc. | Adeno-associated virus compositions for restoring pah gene function and methods of use thereof |
| US10610606B2 (en) | 2018-02-01 | 2020-04-07 | Homology Medicines, Inc. | Adeno-associated virus compositions for PAH gene transfer and methods of use thereof |
| JP7244547B2 (ja) | 2018-02-19 | 2023-03-22 | ホモロジー・メディシンズ・インコーポレイテッド | Ｆ８遺伝子機能を回復させるためのアデノ随伴ウイルス組成物及びその使用の方法 |
| MA51353B1 (fr) | 2018-04-05 | 2022-09-30 | Univ Sorbonne | Sérotype du virus adéno-associé recombinant hybride entre aav9 et aavrh74 possédant un tropisme hépatique réduit |
| CA3100946A1 (en) * | 2018-05-22 | 2019-11-28 | The Brigham And Women's Hospital, Inc. | Gene therapy for alzheimer's disease |
| CN110846392A (zh) * | 2018-08-20 | 2020-02-28 | 武汉纽福斯生物科技有限公司 | 一种重组腺相关病毒或含其的试剂盒及其应用 |
| CA3119349A1 (en) * | 2018-11-16 | 2020-05-22 | Spark Therapeutics, Inc. | In vitro assay for detecting enhancers and inhibitors of adeno associated virus (aav) vector transduction and/or detecting or quantitating anti-aav binding antibodies |
| EP3918308A4 (en) * | 2019-01-31 | 2023-09-27 | Precision Bioservices, Inc. | METHOD FOR DETECTING AND CHARACTERIZING ANTIVIRAL VECTOR ANTIBODIES |
| KR102917057B1 (ko) | 2019-04-24 | 2026-01-23 | 다카라 바이오 가부시키가이샤 | 뇌에 지향성을 가지는 aav 돌연변이체 |
| JP7686573B6 (ja) | 2019-05-24 | 2025-07-04 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | アルツハイマー病のための遺伝子治療 |
| BR112022010373A2 (pt) | 2019-11-29 | 2022-08-16 | Paros Bio Inc | Terapia genética para doenças neurodegenerativas |
| TW202140791A (zh) | 2020-01-13 | 2021-11-01 | 美商霍蒙拉奇醫藥公司 | 治療苯酮尿症之方法 |
| KR20220133969A (ko) | 2020-01-28 | 2022-10-05 | 프리라인 테라퓨틱스 리미티드 | 바이러스 벡터에 대한 중화 항체 역가를 결정하기 위한 개선된 분석법 |
| WO2021209275A1 (en) * | 2020-04-12 | 2021-10-21 | Novoscope Ip Limited | Particles, dna & rna |
| TW202208632A (zh) | 2020-05-27 | 2022-03-01 | 美商同源醫藥公司 | 用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法 |
| EP4421179A3 (en) * | 2020-09-10 | 2024-12-18 | Genethon | Peptide-modified aav capsid |
| CN112143712B (zh) * | 2020-09-30 | 2022-11-01 | 中国科学院深圳先进技术研究院 | 一种重组腺相关病毒及其制备方法和在抗体检测的应用 |
| WO2023114816A1 (en) | 2021-12-14 | 2023-06-22 | Neurogene, Inc. | Recombinant optimized galc constructs and methods for treating galc-associated disorders |
| CN114277090A (zh) * | 2021-12-17 | 2022-04-05 | 宁波熙宁检测技术有限公司 | Aav8中和抗体检测方法和检测试剂盒 |
| GB202201242D0 (en) | 2022-01-31 | 2022-03-16 | Univ Edinburgh | Recombinant optimized mecp2 cassettes and methods for treating rett syndrome and related disorders |
| EP4514984A4 (en) * | 2022-04-25 | 2026-04-22 | Beijing Hanmoluojie Tech Co Ltd | 3D MOLECULAR SURFACE FEATURES MAPPING OF AAV CAPSIDS |
| GB202206336D0 (en) | 2022-04-29 | 2022-06-15 | Univ Edinburgh | Recombinant therapeutic FMR1 constructs and methods of treating fragile X syndrome and related disorders |
| AU2023267671A1 (en) * | 2022-05-13 | 2024-12-05 | The Children's Hospital Of Philadelphia | Adeno-associated viral vectors for targeting brain microvasculature |
| EP4536862A1 (en) * | 2022-06-09 | 2025-04-16 | Wisconsin Alumni Research Foundation | Generation of next generation recombinant aav gene therapy vectors that adopt 3d conformation |
| CN115047188A (zh) * | 2022-06-10 | 2022-09-13 | 上海鼎新基因科技有限公司 | 一种抗腺相关病毒中和抗体的检测方法 |
| CN117802161A (zh) * | 2022-06-30 | 2024-04-02 | 苏州吉恒基因科技有限公司 | 精准重组腺相关病毒载体及其用途 |
| WO2024098054A1 (en) * | 2022-11-04 | 2024-05-10 | The Children's Hospital Of Philadelphia | Compositions and methods for b cell directed immunotherapies for anti-aav neutralizing alloantibodies |
| CN117285620B (zh) * | 2023-11-27 | 2024-02-13 | 恺佧生物科技(上海)有限公司 | 抗aav9抗体及aav9滴度测定elisa试剂盒 |
| WO2025119252A1 (en) * | 2023-12-06 | 2025-06-12 | Immvira Biopharmaceuticals Co., Limited | Methods for detecting an anti-hsv antibody in a sample |
| WO2026017965A1 (en) | 2024-07-19 | 2026-01-22 | The University Court Of The University Of Edinburgh | Recombinant therapeutic fxn constructs and methods of treating friedreich ataxia and related conditions |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0931158A1 (en) | 1996-09-06 | 1999-07-28 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| EP1005376B1 (en) * | 1997-03-14 | 2010-11-03 | The Children's Hospital of Philadelphia | Compositions for use in gene therapy for treatment of hemophilia |
| JP4025400B2 (ja) * | 1997-04-16 | 2007-12-19 | 財団法人化学及血清療法研究所 | 新規免疫制御分子及びその製造方法 |
| WO1999061601A2 (en) * | 1998-05-28 | 1999-12-02 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Aav5 vector and uses thereof |
| ATE362542T1 (de) * | 1998-11-05 | 2007-06-15 | Univ Pennsylvania | Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten |
| US6759237B1 (en) | 1998-11-05 | 2004-07-06 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| DK1035133T3 (da) * | 1999-02-17 | 2005-05-02 | Pfizer Prod Inc | Fusionsproteiner, der omfatter bærere, som kan inducere et dobbelt immunrespons |
| CA2385823A1 (en) * | 1999-10-01 | 2001-04-12 | Haifeng Chen | Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| US7241447B1 (en) * | 1999-10-07 | 2007-07-10 | University Of Iowa Research Foundation | Adeno-associated virus vectors and uses thereof |
| ATE318923T1 (de) * | 2000-06-01 | 2006-03-15 | Univ North Carolina | Doppelsträngige parvovirus-vektoren |
| US20050233457A1 (en) * | 2002-04-15 | 2005-10-20 | Andreas Block | Recombining viral vectors for the tetracycline-regulated expression of genes |
| EP1369491A1 (en) | 2002-06-05 | 2003-12-10 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| AU2003274397A1 (en) * | 2002-06-05 | 2003-12-22 | University Of Florida | Production of pseudotyped recombinant aav virions |
| MXPA04012560A (es) * | 2002-06-13 | 2005-10-19 | Wyeth Corp | Inhibidores de la actividad genica inflamatoria y biosintesis de colesterol. |
| EP2335069A4 (en) * | 2008-09-25 | 2012-08-01 | Univ Duke | METHOD FOR DETECTING ANTIBODIES AND ANTIBODY HIV VIRON COMPLEXES |
| HRP20250897T1 (hr) | 2009-05-02 | 2025-09-26 | Genzyme Corporation | Genska terapija za neurodegenerativne poremećaje |
| KR101464902B1 (ko) * | 2010-08-20 | 2014-11-24 | 나이키 이노베이트 씨.브이. | 골프 클럽 및 골프 클럽 헤드 |
| CN102576029A (zh) | 2010-10-01 | 2012-07-11 | 松下电器产业株式会社 | 从脂质双层膜的外侧向内侧输送钾离子的方法 |
| US8202687B2 (en) | 2010-10-01 | 2012-06-19 | Panasonic Corporation | Method for transporting potassium ions from front side to back side of lipid bilayer membrane |
| BR112013010487B1 (pt) | 2010-11-02 | 2021-02-02 | Promega Corporation | compostos de coelenterazina, kit compreendendo ditos compostos e método para detectar luminescência em uma amostra in vitro |
| EP2675484B1 (en) | 2011-02-14 | 2018-05-30 | The Children's Hospital of Philadelphia | Improved aav8 vector with enhanced functional activity and methods of use thereof |
| CN103014064A (zh) * | 2011-09-22 | 2013-04-03 | 北京五加和分子医学研究所有限公司 | Itr同向排列的aav载体构建及其应用 |
| HK1202434A1 (en) * | 2011-11-22 | 2015-10-02 | The Children's Hospital Of Philadelphia | Virus vectors for highly efficient transgene delivery |
-
2014
- 2014-07-11 HK HK16110663.7A patent/HK1222673A1/zh unknown
- 2014-07-11 EP EP21209775.2A patent/EP4039813A1/en active Pending
- 2014-07-11 AU AU2014287005A patent/AU2014287005C1/en active Active
- 2014-07-11 JP JP2016525827A patent/JP2016525347A/ja active Pending
- 2014-07-11 RU RU2016104614A patent/RU2705249C2/ru not_active Application Discontinuation
- 2014-07-11 WO PCT/US2014/046428 patent/WO2015006743A1/en not_active Ceased
- 2014-07-11 MX MX2016000345A patent/MX2016000345A/es unknown
- 2014-07-11 US US14/904,205 patent/US11408899B2/en active Active
- 2014-07-11 CA CA2918038A patent/CA2918038C/en active Active
- 2014-07-11 CN CN202310061410.6A patent/CN116004721A/zh active Pending
- 2014-07-11 EP EP14823769.6A patent/EP3019620A4/en not_active Withdrawn
- 2014-07-11 CN CN201480039270.1A patent/CN105518145A/zh active Pending
- 2014-07-11 KR KR1020167003572A patent/KR102445330B1/ko active Active
-
2015
- 2015-12-31 IL IL243438A patent/IL243438B/en active IP Right Grant
-
2016
- 2016-01-11 MX MX2021000675A patent/MX2021000675A/es unknown
-
2019
- 2019-04-04 JP JP2019072287A patent/JP2019162109A/ja active Pending
-
2021
- 2021-12-02 JP JP2021195840A patent/JP2022037027A/ja active Pending
-
2022
- 2022-06-30 US US17/855,571 patent/US20220334126A1/en not_active Abandoned
-
2023
- 2023-12-01 JP JP2023204220A patent/JP2024026253A/ja active Pending
-
2025
- 2025-10-24 US US19/368,502 patent/US20260043810A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL243438A0 (en) | 2016-03-31 |
| EP4039813A1 (en) | 2022-08-10 |
| IL243438B (en) | 2020-02-27 |
| AU2014287005C1 (en) | 2021-06-03 |
| CA2918038C (en) | 2023-03-28 |
| US11408899B2 (en) | 2022-08-09 |
| US20260043810A1 (en) | 2026-02-12 |
| RU2016104614A3 (https=) | 2018-03-05 |
| KR102445330B1 (ko) | 2022-09-19 |
| JP2016525347A (ja) | 2016-08-25 |
| JP2019162109A (ja) | 2019-09-26 |
| EP3019620A4 (en) | 2017-01-18 |
| US20220334126A1 (en) | 2022-10-20 |
| MX2021000675A (es) | 2021-03-25 |
| US20160123990A1 (en) | 2016-05-05 |
| CA2918038A1 (en) | 2015-01-15 |
| EP3019620A1 (en) | 2016-05-18 |
| CN116004721A (zh) | 2023-04-25 |
| MX2016000345A (es) | 2016-06-21 |
| JP2024026253A (ja) | 2024-02-28 |
| AU2014287005B2 (en) | 2020-12-17 |
| RU2705249C2 (ru) | 2019-11-06 |
| CN105518145A (zh) | 2016-04-20 |
| RU2016104614A (ru) | 2017-08-18 |
| WO2015006743A1 (en) | 2015-01-15 |
| JP2022037027A (ja) | 2022-03-08 |
| AU2014287005A1 (en) | 2016-01-28 |
| KR20160034332A (ko) | 2016-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1222673A1 (zh) | Aav载体和用於抗aav(腺相关病毒)中和抗体的检测 | |
| MX2021005727A (es) | Ensayo in vitro para detectar potenciadores e inhibidores de la transducción de vectores virales adenoasociados (aav) y/o para detectar o cuantificar anticuerpos de unión anti-aav. | |
| HK1254633A1 (zh) | 用於分析样品，尤其是血液，的装置和系统以及使用它的方法 | |
| PH12018502389A1 (en) | Immunochromatography analysis device for detecting zika virus | |
| WO2014015194A3 (en) | Methods for detecting and measuring aggregation | |
| WO2014165082A3 (en) | Antibodies and methods of detection | |
| JO3812B1 (ar) | أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1) | |
| WO2015038884A3 (en) | Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products | |
| EP2839266A4 (en) | METHOD AND SYSTEMS FOR DETECTING AN ANALYTE OR CLASSIFYING A SAMPLE | |
| EP2895970A4 (en) | SYSTEMS AND METHODS OF COLLECTING, ANALYZING AND SHARING BIOSIGNAL AND NON-BIOSIGNAL DATA | |
| ZA202002415B (en) | Detection of symmetrical dimethylarginine | |
| BR112015023894A2 (pt) | sistema e método para determinação de propriedades de uma amostra | |
| BR112017017854A2 (pt) | método para detecção de anticorpo monoclonal utilizando espectrometria de massa | |
| EA201690731A1 (ru) | Анализ igfbp7, имеющий улучшенную характеристику в биологических образцах | |
| WO2014144725A3 (en) | Melatonin monoclonal antibody, detection, methods and uses thereof | |
| EA201892325A1 (ru) | Композиции и способы детектирования белков клетки-хозяина | |
| WO2011127488A3 (en) | Systems and methods of processing data associated with detection and/or handling of malware | |
| WO2016209773A9 (en) | Improved assays and methods for allergen detection | |
| EA201891002A1 (ru) | Иммунологический анализ для определения расщепленного высокомолекулярного кининогена | |
| EA201991506A1 (ru) | Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов | |
| WO2013115410A3 (en) | Anti-phospholipase d4 antibody | |
| BR112018013381A2 (pt) | anticorpo especificamente ligante a antígenos derivados de miobacteria ou fragmento ligante a antígeno do mesmo | |
| WO2014039605A3 (en) | Chimeric anti-dsdna/chromatin antibody | |
| EA201400571A1 (ru) | Специфичные к трансресвератролу антитела и их применение | |
| WO2014145243A3 (en) | High resolution melting analysis assay for the detection of viral dna |